Repurposed Drugs Reshape Pricing Debate
Study models sustainable pricing for repurposed bevacizumab
False
Study models sustainable pricing for repurposed bevacizumab
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
May 27, 2025
6 min read
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
December 1, 2014
0 min read
Upstream processes in biopharma manufacturing are growing ever more efficient; conversely, downstream processing is increasingly a bottleneck. Can a new generation of chromatography techniques and technologies get things moving again?
April 2, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
April 7, 2025
6 min read
Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.
False
Affiliations:
Specialties:
Areas of Expertise: